62 related articles for article (PubMed ID: 3395402)
1. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers.
Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402
[TBL] [Abstract][Full Text] [Related]
2. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Hänninen U; Välttilä S
Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390
[TBL] [Abstract][Full Text] [Related]
3. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
Mäntylä R; Männistö PT; Vuorela A; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the safety margin of vadocaine hydrochloride in man.
Karttunen P; Uusitupa M; Helin M; Tukiainen H; Silvasti M
Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404
[TBL] [Abstract][Full Text] [Related]
5. First human studies on the safety and antitussive activity of vadocaine hydrochloride.
Karttunen P; Tukiainen H; Uusitupa M; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers.
Karttunen P
Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403
[TBL] [Abstract][Full Text] [Related]
7. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Ottoila P
Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography.
Vuorela A; Mäntylä R; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400
[TBL] [Abstract][Full Text] [Related]
9. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.
Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW
Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394
[TBL] [Abstract][Full Text] [Related]
10. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride.
Karttunen P; Männistö PT; Lahovaara S; Havas A
Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice.
Etemadzadeh E; Ahtee L; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs.
Paakkari I; Svartström-Fraser M
Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs.
Salonen RO
Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
19. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers.
Rodríguez CA; Azie NE; Adams G; Donaldson K; Francom SF; Staton BA; Bombardt PA
J Clin Pharmacol; 2004 Mar; 44(3):276-83. PubMed ID: 14973308
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
